Verma, M., Beaulieu-Abdelahad, D., Ait-Ghezala, G., Li, R., Crawford, F., Mullan, M., & Paris, D. (2015). Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. PLoS One.
Citación estilo ChicagoVerma, Megha, David Beaulieu-Abdelahad, Ghania Ait-Ghezala, Rena Li, Fiona Crawford, Michael Mullan, y Daniel Paris. "Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD." PLoS One 2015.
Cita MLAVerma, Megha, et al. "Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD." PLoS One 2015.